Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
L Degenhardt, B Clark, G Macpherson… - The Lancet …, 2023 - thelancet.com
Background Opioid dependence is associated with substantial health and social burdens,
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …
Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
[HTML][HTML] Lower urinary tract symptoms in depression: a review
DJ Anderson, A Aucoin, CR Toups… - Health psychology …, 2023 - ncbi.nlm.nih.gov
Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …
population as patients age with approximately a third of individuals experiencing LUTS …
COVID-19 and the health of people who use drugs: What is and what could be?
Abstract SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in …
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in …
[HTML][HTML] Tracing the affordances of long-acting injectable depot buprenorphine: a qualitative study of patients' experiences in Australia
Background Long-acting injectable depot buprenorphine is an important new treatment
option for the management of opioid dependence, delivering therapeutic doses in weekly or …
option for the management of opioid dependence, delivering therapeutic doses in weekly or …
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot
Introduction Stigma has corrosive effects on all aspects of care and can undermine
individual and population health outcomes. Addiction-related stigma has implications for …
individual and population health outcomes. Addiction-related stigma has implications for …
[HTML][HTML] Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
Background Opioid agonist treatment (OAT) is an effective intervention for opioid
dependence. Extended-release buprenorphine injections (BUP-XR) may have additional …
dependence. Extended-release buprenorphine injections (BUP-XR) may have additional …
Endogenous opiates and behavior: 2022
RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …
research concerning the endogenous opioid system, summarizing articles published during …
[HTML][HTML] Buprenorphine and its formulations: a comprehensive review
S Poliwoda, N Noor, JS Jenkins, CW Stark… - Health Psychology …, 2022 - ncbi.nlm.nih.gov
Buprenorphine, a novel long-acting analgesic, was developed with the intention of two
purposes: analgesia and opioid use disorder. Regarding its pharmacodynamics, it is a …
purposes: analgesia and opioid use disorder. Regarding its pharmacodynamics, it is a …
The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study
Background Injecting-related bacterial and fungal infections cause substantial illness and
disability among people who use illicit drugs. Opioid agonist treatment (OAT) reduces …
disability among people who use illicit drugs. Opioid agonist treatment (OAT) reduces …